Mucus Permeating Nanoparticulate Drug Delivery Systems
The objective of the ALEXANDER project is the identification of novel strategies (e.g., proteolytic enzyme strategy, thiomer strategy, zeta potential changing systems, SNEDDS strategy) and the optimization of existing strategies (...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
NANOLEM
Understanding the physico chemical basis of transdermal drug...
231K€
Cerrado
SAF2016-79230-R
NUEVA ESTRATEGIA MULTI-ETAPA PARA LA LIBERACION ORAL DE BIOM...
97K€
Cerrado
INTESTINANOS
Intestinal Lipoidal Nanostructures A Lipid Bridge to Incre...
2M€
Cerrado
BES-2010-030593
MODIFICACION DE CAPSIDAS VIRICAS POR INGENIERIA DE PROTEINAS...
43K€
Cerrado
CTQ2015-72605-EXP
EXPLORACION DE LA POROSIDAD EN NANOPARTICULAS DE ORO
15K€
Cerrado
NANOZID
DNA nanohydrogel loaded Liposomal formulations for high load...
214K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The objective of the ALEXANDER project is the identification of novel strategies (e.g., proteolytic enzyme strategy, thiomer strategy, zeta potential changing systems, SNEDDS strategy) and the optimization of existing strategies (e.g., disulfide breaking strategy and slippery surface strategy) for the efficient transport of nanocarriers through the mucus gel layer (e.g., intestinal, nasal, ocular, vaginal, buccal, pulmonary). In particular, R&D activities will be focused on the synthesis of functionalized nanocarriers capable of permeating the mucus gel layer and delivering their therapeutic payload to the epithelium. The nanocarriers will be characterized with respect to their physicochemical properties, ability to cross the mucus gel layer, in vitro and in vivo cytotoxicity. The potential of the developed nanocarriers as delivery systems for mucosal administration of macromolecules will be demonstrated via the oral delivery of peptides, oligosaccharides and oligonucleotides and the nasal delivery of a plasmid encoding for an antigen.